2017
DOI: 10.1093/rheumatology/kex062.115
|View full text |Cite
|
Sign up to set email alerts
|

115. survival Analysis and Reasons for Discontinuing or Switching Tumour Necrosis Factor Inhibitors in Axial Spondyloarthritis: Findings From a Real-Life Uk Cohort

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles